Kenjiro Kotake

City Hospital — United Kingdom

Medicine · Health Sciences

32h-index9.3kcitations190works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(68), Colorectal Cancer Surgical Treatments(59), Gastric Cancer Management and Outcomes(48), Colorectal and Anal Carcinomas(33), Genetic factors in colorectal cancer(28)

Publications190 total

Investigation of Peritoneal Lavage Cytology before and after Tumor Resection as a Prognostic Factor in Colorectal Cancer
Journal of the Anus Rectum and Colon·2025Open Access
30.6 A 64Gb DDR4 STT-MRAM Using a Time-Controlled Discharge-Reading Scheme for a .001681\mu\mathrm{m}$ 1T-1MTJ Cross-Point Cell
2025· 3 cited
Factors Affecting the Prognosis after Primary Tumor Resection for Patients with Metastatic Colorectal Cancer with Synchronous Peritoneal Metastasis: A Multi-center, Prospective, Observational Study
Journal of the Anus Rectum and Colon·2025· 1 citedOpen Access
Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases
Annals of Gastroenterological Surgery·2025· 1 citedOpen Access
Comprehensive data of 5085 patients newly diagnosed with colorectal liver metastasis between 2013 and 2017: Fourth report of a nationwide survey in Japan
Journal of Hepato-Biliary-Pancreatic Sciences·2024· 2 citedOpen Access
Evaluation of two-stage hepatectomy using portal vein embolization for colorectal liver metastasis: a retrospective nationwide cohort survey in Japan
International Journal of Surgery·2024Open Access
Peritoneal lavage cytology in patients with curative resection for stage <scp>II</scp> and <scp>III</scp> colorectal cancer: A multi‐institutional prospective study
Annals of Gastroenterological Surgery·2024· 1 citedOpen Access
Peritoneal lavage cytology in patients with curative resection for stage II and III colorectal cancer: A multi-institutional prospective study.
Journal of Clinical Oncology·2024
A proposed new Japanese classification of synchronous peritoneal metastases from colorectal cancer: A multi‐institutional, prospective, observational study conducted by the Japanese Society for Cancer of the Colon and Rectum
Annals of Gastroenterological Surgery·2023· 3 citedOpen Access
Supplementary Table 1 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Tables 3 through 6 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Table 2 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Figures 1 through 6 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Data from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Figures 1 through 6 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Table 2 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table Legends from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Data from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Tables 3 through 6 from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table Legends from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Kenichi Sugihara(33), Keiichi Takahashi(16), Toshiaki Watanabe(11), Yojiro Hashiguchi(10), Michio Itabashi(9), Hirotoshi Kobayashi(9), Shingo Kameoka(8), Megumi Ishiguro(7), Yukihide Kanemitsu(7), Koutarou Maeda(7), Tetsuichiro Muto(7), Yasuo Koyama(7), Heita Ozawa(7), Yoshiharu Sakai(6), Hideki Ueno(6), Takayuki Morita(6), Kazuo Hase(6), Kazuo Shirouzu(6), Hideyuki Ishida(5), Yusuke Kinugasa(5)